Biosimilar medicines for pharmacistsBack to previous page
php echo wp_list_categories(); ?>
Biosimilar medicines are becoming increasingly available in Australia and have the potential to provide significant savings to the health care system and improve patient care. This module will provide you with the knowledge you need to talk to your patients about biosimilar medicines and what these medicines mean for them. You will be asked to answer questions throughout the module to reinforce learning.
This online learning program has been developed to support pharmacists in understanding the development, safety, regulation and uses of biosimilar medicines.
Accreditation number: CONL1711
This activity has been accredited for 1 hour of Group 1 CPD suitable for inclusion in an individual pharmacist’s CPD plan. Up to 1 hour of Group 1 activity may be converted to Group 2 (or 2 CPD credits) upon successful completion of relevant assessment activities.
PSA gratefully acknowledges the Australian Government Department of Health for providing funding for this module as part of the PBS Access and Sustainability Package including the Sixth Community Pharmacy Agreement.
To view the Practical considerations associated with biosimilar medicines recorded lecture, click here.
This item is listed in the following categories: • Public CPD